Results 71 to 80 of about 83,877 (250)

International Guillain-Barré Syndrome Outcome Study (IGOS): protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome [PDF]

, 2017
Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy with a highly variable clinical presentation, course, and outcome. The factors that determine the clinical variation of GBS are poorly understood which complicates the care and treatment of
Bateman, K., Chavada, Govindsinh, Cornblath, D. R., Cornblath, David R., Dardiotis, E., Faber, C. G., Feasby, T. E., Gorson, K. C., Gorson, Kenneth C., Harbo, T., Harbo, Thomas, Hartung, H. P., Hartung, H. P., Hartung, Hans Peter, Hughes, R. A.C., Hughes, Richard A.C., Illa, I., Islam, B., Islam, Z., Jacobs, B. C., Jacobs, B. C., Jacobs, B. C., Jacobs, Bart C., Kusunoki, S., Kusunoki, S., Kusunoki, Susumu, Lehmann, H. C., Mohammad, Q. D., Nobile-Orazio, E., Péréon, Y., Reddel, S. W., Reisin, R. C., Roodbol, J., Shahrizaila, N., van den Berg, B., van den Berg, B., van den Berg, Bianca, van den Bergh, P., van der Kooi, A. J., van Dijk, G. W., van Doorn, P. A., van Doorn, Pieter A., van Woerkom, M., Verboon, C., Verboon, C., Verboon, Christine, Visser, L. H., Wang, Y. Z., Willison, H. J., Willison, Hugh J.   +49 more
core   +3 more sources

IVIG regulates the survival of human but not mouse neutrophils

Scientific Reports, 2017
Intravenous immunoglobulin (IVIG) are purified IgG preparations made from the pooled plasma from thousands of healthy donors and are being tested in preclinical mouse models.
C. Schneider, S. Wicki, S. Graeter, T. M. Timcheva, C. Keller, Isaak Quast, D. Leontyev, I. Djoumerska-Alexieva, F. Käsermann, S. Jakob, P. Dimitrova, D. Branch, R. Cummings, J. Lünemann, T. Kaufmann, H. Simon, S. von Gunten   +16 more
semanticscholar   +1 more source

Outcome of Patients with Gullain Barre syndrome at Tertiary Care Hospital in Eastern Nepal

Journal of Nobel Medical College, 2018
Background: Gullain Barre syndrome is the most common cause of acute flaccid paralysis. Early diagnosis and treatment improves survival in patients with Gullain Barre Syndrome.
Dilli Ram Kafle, Surendra Shah
doaj   +1 more source

Distinctive serum lipidomic profile of IVIG-resistant Kawasaki disease children before and after treatment.

PLoS ONE, 2023
Kawasaki Disease (KD) is an acute inflammatory disorder associated with systemic vasculitis. Intravenous immunoglobulin (IVIG) is an effective therapy for KD, yet, about 20% of cases show IVIG resistance with persistent inflammation. The lipid profile in
Zhen Chen, Shuji Sai, Kiyoshi Nagumo, Yue Wu, Hitoshi Chiba, Shu-Ping Hui   +5 more
doaj   +1 more source

Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. [PDF]

, 2019
Background Accurate prediction of coronary artery aneurysms ( CAAs ) in patients with Kawasaki disease remains challenging in North American cohorts. We sought to develop and validate a risk model for CAA prediction.
Baker, Annette L, Burns, Jane C, de Ferranti, Sarah, Dedeoglu, Fatma, Friedman, Kevin G, Gauvreau, Kimberlee, Lo, Mindy, Newburger, Jane W, Son, Mary Beth F, Sundel, Robert P, Tremoulet, Adriana H   +10 more
core  

Maternal Immune Thrombocytopenic Purpura Leading to Severe Neonatal Autoimmune Thrombocytopenia: Report of Two Cases

National Board of Examinations Journal of Medical Sciences
Introduction: In neonatal intensive care units, neonatal thrombocytopenia is one of the common hematological abnormality seen. Neonatal autoimmune thrombocytopenia should be considered in any neonate who is born to a known case of immune thrombocytopenia
Khushwant Kaur, Varughese PV, Nidhie Shajan   +2 more
doaj   +1 more source

Acute Jaundice in a Six-year-old: An Unusual Presentation of Atypical Kawasaki Disease [PDF]

, 2020
Kawasaki disease (KD) is a rare vasculitis of childhood that is critical to recognize and treat due to associated morbidity and mortality. A six-year-old male presented to our emergency department (ED) afebrile but with reported recent fevers.
Bylund, LCDR William, Morrison Ponce, LCDR Daphne, Zarow, Gregory J.   +2 more
core  

Intravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's disease [PDF]

, 2014
Intravenous immunoglobulin (IVIG) has shown limited promise so far in human clinical studies on Alzheimer's disease (AD), yet overwhelmingly positive preclinical work in animals and human brain cultures support the notion that the therapy remains ...
Counts, Scott, He, Bin, Lahiri, Debomoy K., Mufson, Elliott J., Perez, Sylvia E., Ray, Balmiki   +5 more
core   +1 more source

Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT

Efficacy and Mechanism Evaluation
Background There are data suggesting that intravenous immunoglobulin treatment has some benefit for certain forms of encephalitis but robust evidence from large randomised controlled trials in children with all-cause encephalitis is lacking. Objective To
Mildred A Iro, Manish Sadarangani, Michael Absoud, Liberty Cantrell, Wui K Chong, Christopher Clark, Ava Easton, Victoria Gray, Matilda Hill, Rachel Kneen, Ming Lim, Xinxue Liu, Mike Pike, Tom Solomon, Angela Vincent, Louise Willis, Ly-Mee Yu, Andrew J Pollard,   +18 more
doaj   +1 more source

Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis [PDF]

, 2005
Objective Our aim is to present the disease course, frequency of relapses and survival of juvenile and adult dermatomyositis (JDM/DM) patients. Methods Analysis was performed using data on 73 patients. The median follow-up for 38 JDM patients was
Balogh, Zsolt, Borgulya, Gábor, Constantin, Tamás, Dankó, K., Fekete, György, Garami, Miklós, Molnár, K., Ponyi, Andrea, Szalai, Zsuzsanna, Tefner, I.   +9 more
core